| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |